Ian Hastings[Author] - Search Results

Year	Number of Results
2002	2
2003	2
2004	5
2005	7
2006	6
2007	6
2008	2
2009	2
2010	5
2011	9
2012	5
2013	3
2014	3
2015	5
2016	5
2017	1
2018	2
2019	3
2020	4
2021	2
2022	2
2023	2
2024	1

1

Deciphering the signatures of artemisinin resistance.

Hastings IM. Hastings IM. J Antimicrob Chemother. 2024 Jan 3;79(1):203-204. doi: 10.1093/jac/dkad366. J Antimicrob Chemother. 2024. PMID: 38019671 No abstract available.

2

WHO antimalarial trial guidelines: good science, bad news?

Hastings IM, Felger I. Hastings IM, et al. Trends Parasitol. 2022 Nov;38(11):933-941. doi: 10.1016/j.pt.2022.08.005. Epub 2022 Sep 3. Trends Parasitol. 2022. PMID: 36068129 Review.

3

PCR correction strategies for malaria drug trials: updates and clarifications.

Felger I, Snounou G, Hastings I, Moehrle JJ, Beck HP. Felger I, et al. Among authors: hastings i. Lancet Infect Dis. 2020 Jan;20(1):e20-e25. doi: 10.1016/S1473-3099(19)30426-8. Epub 2019 Sep 17. Lancet Infect Dis. 2020. PMID: 31540841 Review.

4

The origins of antimalarial drug resistance.

Hastings IM. Hastings IM. Trends Parasitol. 2004 Nov;20(11):512-8. doi: 10.1016/j.pt.2004.08.006. Trends Parasitol. 2004. PMID: 15471702 Review.

5

Mathematical models of human african trypanosomiasis epidemiology.

Rock KS, Stone CM, Hastings IM, Keeling MJ, Torr SJ, Chitnis N. Rock KS, et al. Among authors: hastings im. Adv Parasitol. 2015 Mar;87:53-133. doi: 10.1016/bs.apar.2014.12.003. Epub 2015 Feb 11. Adv Parasitol. 2015. PMID: 25765194 Free article. Review.

6

Tolerance is the key to understanding antimalarial drug resistance.

Hastings IM, Watkins WM. Hastings IM, et al. Trends Parasitol. 2006 Feb;22(2):71-7. doi: 10.1016/j.pt.2005.12.011. Epub 2006 Jan 10. Trends Parasitol. 2006. PMID: 16406706 Review.

7

Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices.

Yeung S, Pongtavornpinyo W, Hastings IM, Mills AJ, White NJ. Yeung S, et al. Among authors: hastings im. Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):179-86. Am J Trop Med Hyg. 2004. PMID: 15331836 Free article. Review.

8

The impact of antimalarial drug resistance mutations on parasite fitness, and its implications for the evolution of resistance.

Hastings IM, Donnelly MJ. Hastings IM, et al. Drug Resist Updat. 2005 Feb-Apr;8(1-2):43-50. doi: 10.1016/j.drup.2005.03.003. Epub 2005 Apr 18. Drug Resist Updat. 2005. PMID: 15939341 Review.

9

Pharmacological considerations in the design of anti-malarial drug combination therapies - is matching half-lives enough?

Hastings IM, Hodel EM. Hastings IM, et al. Malar J. 2014 Feb 20;13:62. doi: 10.1186/1475-2875-13-62. Malar J. 2014. PMID: 24552440 Free PMC article. Review.

10

Intensity of malaria transmission and the evolution of drug resistance.

Hastings IM, Watkins WM. Hastings IM, et al. Acta Trop. 2005 Jun;94(3):218-29. doi: 10.1016/j.actatropica.2005.04.003. Epub 2005 Apr 19. Acta Trop. 2005. PMID: 15847846 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

80 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year